Faster Genomics-Based Diagnosis May Accelerate Treatment of Myeloid Neoplasms Patients
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Leukemia |
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Diagnostic Technologies, Disease States |
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Kidney Disease |
Natera detailed a paper highlighting the clinical utility of its comprehensive kidney gene panel Renasight in aiding kidney disease diagnosis.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Disease States |
The NCCHD in Japan and OmniTier detailed how the company’s genomic analysis platform improved diagnostic rates for rare diseases.
Read MorePosted by Andy Lundin | Feb 2, 2023 | Prostate |
Investigators found that the test was able to distinguish cancer localized to the prostate from cancer that spread to other parts of the body.
Read More